These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30036222)

  • 1. Treatment-Related Radiation Toxicity Among Cervical Cancer Patients.
    Rubinsak LA; Kang L; Fields EC; Carter JS; McGuire WP; Temkin SM
    Int J Gynecol Cancer; 2018 Sep; 28(7):1387-1393. PubMed ID: 30036222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated Radiotherapy.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Wu CJ; Tai HC; Hsu SM; Chen YJ
    Int J Gynecol Cancer; 2018 Sep; 28(7):1377-1386. PubMed ID: 29994908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.
    Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer.
    Annede P; Mailleux H; Sfumato P; Ferré M; Autret A; Varela Cagetti L; Macagno A; Fau P; Chargari C; Tallet A; Resbeut M; Zemmour C; Gonzague L; Boher JM
    Brachytherapy; 2018; 17(6):922-928. PubMed ID: 30061056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
    Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
    Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
    Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].
    Gamelon-Bénichou C; Oldrini S; Charra-Brunaud C; Vogin G; Salleron J; Peiffert D
    Cancer Radiother; 2017 May; 21(3):171-179. PubMed ID: 28457817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
    Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
    Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced toxicity with equivalent outcomes using three-dimensional volumetric (3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population.
    Thomas KM; Maquilan G; Stojadinovic S; Medin P; Folkert MR; Albuquerque K
    Brachytherapy; 2017; 16(5):943-948. PubMed ID: 28602708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
    Gao K; Ding L; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
    Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
    Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
    Li XL; Chen ZY; Cui YC; Sheng XG
    Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
    Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
    Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation reactions.
    Bohr Mordhorst L; Karlsson L; Bärmark B; Sorbe B
    Int J Gynecol Cancer; 2014 Sep; 24(7):1268-75. PubMed ID: 25078336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.